Dr. Akhave is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-792-3708
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2014 - 2017
University of Missouri Kansas City School of MedicineClass of 2014
Certifications & Licensure
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025
OK State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsImmunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment.Neal Akhave, Jiexin Zhang, Erin Bayley, Meredith Frank, Shin-Heng Chiou
Lung Cancer. 2022-10-01 - 6 citationsThe Next Generation of KRAS Targeting: Reasons for Excitement and Concern.Neal S Akhave, Amadeo B Biter, David S Hong
Molecular Cancer Therapeutics. 2022-11-03 - 38 citationsMechanisms of Resistance to KRASG12C-Targeted Therapy.Neal Akhave, Amadeo B. Biter, David S. Hong
Cancer Discovery. 2021-04-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
